Replimune Group, Inc. (REPL)

7.95 -0.59 (-6.91%) USD  |  NASDAQ  |  Apr 07, 12:58
More

Replimune Group Total Depreciation, Amortization, Depletion (Semi Annual)

Total Depreciation, Amortization, Depletion (Semi Annual) Chart

View Total Depreciation, Amortization, Depletion (Semi Annual) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Depreciation, Amortization, Depletion (Semi Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Depreciation, Amortization, Depletion (Semi Annual) Range, Past 5 Years

View Total Depreciation, Amortization, Depletion (Semi Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Depreciation, Amortization, Depletion (Semi Annual) Benchmarks

View Total Depreciation, Amortization, Depletion (Semi Annual) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. --
Phathom Pharmaceuticals, Inc. --
REGENXBIO, Inc. --
Corcept Therapeutics, Inc. --
Catalyst Pharmaceuticals, Inc. --